Industry Research Reports

Home > Reports > Pharma & Healthcare > Recombinant Coagulation Factor Concentrate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Recombinant Coagulation Factor Concentrate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-11-19

Pages: 147 Pages

Report ld: 3381859

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Recombinant Coagulation Factor Concentrate was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.

Coagulation factor is the main drug for the treatment of hemophilia, and it has experienced the evolution and development from the first generation blood-derived coagulation factor products to the second generation recombinant products and the third generation long-acting recombinant products. Recombinant coagulation factors avoid the possibility of human infection and get rid of the dependence on plasma; long-acting products improve patient compliance and treatment convenience by prolonging the half-life of drugs, and long-acting recombinant coagulation factors are the trend of future research and development.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines. Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

This report aims to provide a comprehensive presentation of the global market for Recombinant Coagulation Factor Concentrate, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Recombinant Coagulation Factor Concentrate by region & country, by Type, and by Application.

The Recombinant Coagulation Factor Concentrate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Coagulation Factor Concentrate.

Market Segmentation

Report Metric
Details
Report Title
Recombinant Coagulation Factor Concentrate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Recombinant Coagulation Factor Concentrate Companies Covered
Bayer, Alprolix, Benefix, Idelvion, Lxinity, Rebinyn, Rixubis, CSL, Baxalta, Sanofi, Biogen, Pfizer, Novo Disk, Baxter, Wyeth, Beijing Tiantan Biological Products, SHANGHAI RAAS, Taibang Biologic Group, HUALAN BIOLOGICAL ENGINEERING, Green Cross
Global Recombinant Coagulation Factor Concentrate Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Recombinant Coagulation Factor Concentrate Market, Segment by Type
250 IU

500 IU

1000 IU

2000 IU
Global Recombinant Coagulation Factor Concentrate Market, Segment by Application
Hopistial

Clinic

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Recombinant Coagulation Factor Concentrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Recombinant Coagulation Factor Concentrate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Recombinant Coagulation Factor Concentrate in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Recombinant Coagulation Factor Concentrate Product Introduction
    1.2 Global Recombinant Coagulation Factor Concentrate Market Size Forecast
        1.2.1 Global Recombinant Coagulation Factor Concentrate Sales Value (2019-2030)
        1.2.2 Global Recombinant Coagulation Factor Concentrate Sales Volume (2019-2030)
        1.2.3 Global Recombinant Coagulation Factor Concentrate Sales Price (2019-2030)
    1.3 Recombinant Coagulation Factor Concentrate Market Trends & Drivers
        1.3.1 Recombinant Coagulation Factor Concentrate Industry Trends
        1.3.2 Recombinant Coagulation Factor Concentrate Market Drivers & Opportunity
        1.3.3 Recombinant Coagulation Factor Concentrate Market Challenges
        1.3.4 Recombinant Coagulation Factor Concentrate Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Recombinant Coagulation Factor Concentrate Players Revenue Ranking (2023)
    2.2 Global Recombinant Coagulation Factor Concentrate Revenue by Company (2019-2024)
    2.3 Global Recombinant Coagulation Factor Concentrate Players Sales Volume Ranking (2023)
    2.4 Global Recombinant Coagulation Factor Concentrate Sales Volume by Company Players (2019-2024)
    2.5 Global Recombinant Coagulation Factor Concentrate Average Price by Company (2019-2024)
    2.6 Key Manufacturers Recombinant Coagulation Factor Concentrate Manufacturing Base and Headquarters
    2.7 Key Manufacturers Recombinant Coagulation Factor Concentrate Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Recombinant Coagulation Factor Concentrate
    2.9 Recombinant Coagulation Factor Concentrate Market Competitive Analysis
        2.9.1 Recombinant Coagulation Factor Concentrate Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Recombinant Coagulation Factor Concentrate Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Coagulation Factor Concentrate as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 250 IU
        3.1.2 500 IU
        3.1.3 1000 IU
        3.1.4 2000 IU
    3.2 Global Recombinant Coagulation Factor Concentrate Sales Value by Type
        3.2.1 Global Recombinant Coagulation Factor Concentrate Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Recombinant Coagulation Factor Concentrate Sales Value, by Type (2019-2030)
        3.2.3 Global Recombinant Coagulation Factor Concentrate Sales Value, by Type (%) (2019-2030)
    3.3 Global Recombinant Coagulation Factor Concentrate Sales Volume by Type
        3.3.1 Global Recombinant Coagulation Factor Concentrate Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Recombinant Coagulation Factor Concentrate Sales Volume, by Type (2019-2030)
        3.3.3 Global Recombinant Coagulation Factor Concentrate Sales Volume, by Type (%) (2019-2030)
    3.4 Global Recombinant Coagulation Factor Concentrate Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hopistial
        4.1.2 Clinic
        4.1.3 Others
    4.2 Global Recombinant Coagulation Factor Concentrate Sales Value by Application
        4.2.1 Global Recombinant Coagulation Factor Concentrate Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Recombinant Coagulation Factor Concentrate Sales Value, by Application (2019-2030)
        4.2.3 Global Recombinant Coagulation Factor Concentrate Sales Value, by Application (%) (2019-2030)
    4.3 Global Recombinant Coagulation Factor Concentrate Sales Volume by Application
        4.3.1 Global Recombinant Coagulation Factor Concentrate Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Recombinant Coagulation Factor Concentrate Sales Volume, by Application (2019-2030)
        4.3.3 Global Recombinant Coagulation Factor Concentrate Sales Volume, by Application (%) (2019-2030)
    4.4 Global Recombinant Coagulation Factor Concentrate Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Recombinant Coagulation Factor Concentrate Sales Value by Region
        5.1.1 Global Recombinant Coagulation Factor Concentrate Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Recombinant Coagulation Factor Concentrate Sales Value by Region (2019-2024)
        5.1.3 Global Recombinant Coagulation Factor Concentrate Sales Value by Region (2025-2030)
        5.1.4 Global Recombinant Coagulation Factor Concentrate Sales Value by Region (%), (2019-2030)
    5.2 Global Recombinant Coagulation Factor Concentrate Sales Volume by Region
        5.2.1 Global Recombinant Coagulation Factor Concentrate Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Recombinant Coagulation Factor Concentrate Sales Volume by Region (2019-2024)
        5.2.3 Global Recombinant Coagulation Factor Concentrate Sales Volume by Region (2025-2030)
        5.2.4 Global Recombinant Coagulation Factor Concentrate Sales Volume by Region (%), (2019-2030)
    5.3 Global Recombinant Coagulation Factor Concentrate Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Recombinant Coagulation Factor Concentrate Sales Value, 2019-2030
        5.4.2 North America Recombinant Coagulation Factor Concentrate Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Recombinant Coagulation Factor Concentrate Sales Value, 2019-2030
        5.5.2 Europe Recombinant Coagulation Factor Concentrate Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Recombinant Coagulation Factor Concentrate Sales Value, 2019-2030
        5.6.2 Asia Pacific Recombinant Coagulation Factor Concentrate Sales Value by Region (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Recombinant Coagulation Factor Concentrate Sales Value, 2019-2030
        5.7.2 South America Recombinant Coagulation Factor Concentrate Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Recombinant Coagulation Factor Concentrate Sales Value, 2019-2030
        5.8.2 Middle East & Africa Recombinant Coagulation Factor Concentrate Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Recombinant Coagulation Factor Concentrate Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Recombinant Coagulation Factor Concentrate Sales Value
        6.2.1 Key Countries/Regions Recombinant Coagulation Factor Concentrate Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Recombinant Coagulation Factor Concentrate Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Recombinant Coagulation Factor Concentrate Sales Value, 2019-2030
        6.3.2 United States Recombinant Coagulation Factor Concentrate Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Recombinant Coagulation Factor Concentrate Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Recombinant Coagulation Factor Concentrate Sales Value, 2019-2030
        6.4.2 Europe Recombinant Coagulation Factor Concentrate Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Recombinant Coagulation Factor Concentrate Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Recombinant Coagulation Factor Concentrate Sales Value, 2019-2030
        6.5.2 China Recombinant Coagulation Factor Concentrate Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Recombinant Coagulation Factor Concentrate Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Recombinant Coagulation Factor Concentrate Sales Value, 2019-2030
        6.6.2 Japan Recombinant Coagulation Factor Concentrate Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Recombinant Coagulation Factor Concentrate Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Recombinant Coagulation Factor Concentrate Sales Value, 2019-2030
        6.7.2 South Korea Recombinant Coagulation Factor Concentrate Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Recombinant Coagulation Factor Concentrate Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Recombinant Coagulation Factor Concentrate Sales Value, 2019-2030
        6.8.2 Southeast Asia Recombinant Coagulation Factor Concentrate Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Recombinant Coagulation Factor Concentrate Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Recombinant Coagulation Factor Concentrate Sales Value, 2019-2030
        6.9.2 India Recombinant Coagulation Factor Concentrate Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Recombinant Coagulation Factor Concentrate Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Company Information
        7.1.2 Bayer Introduction and Business Overview
        7.1.3 Bayer Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.1.4 Bayer Recombinant Coagulation Factor Concentrate Product Offerings
        7.1.5 Bayer Recent Development
    7.2 Alprolix
        7.2.1 Alprolix Company Information
        7.2.2 Alprolix Introduction and Business Overview
        7.2.3 Alprolix Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.2.4 Alprolix Recombinant Coagulation Factor Concentrate Product Offerings
        7.2.5 Alprolix Recent Development
    7.3 Benefix
        7.3.1 Benefix Company Information
        7.3.2 Benefix Introduction and Business Overview
        7.3.3 Benefix Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.3.4 Benefix Recombinant Coagulation Factor Concentrate Product Offerings
        7.3.5 Benefix Recent Development
    7.4 Idelvion
        7.4.1 Idelvion Company Information
        7.4.2 Idelvion Introduction and Business Overview
        7.4.3 Idelvion Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.4.4 Idelvion Recombinant Coagulation Factor Concentrate Product Offerings
        7.4.5 Idelvion Recent Development
    7.5 Lxinity
        7.5.1 Lxinity Company Information
        7.5.2 Lxinity Introduction and Business Overview
        7.5.3 Lxinity Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.5.4 Lxinity Recombinant Coagulation Factor Concentrate Product Offerings
        7.5.5 Lxinity Recent Development
    7.6 Rebinyn
        7.6.1 Rebinyn Company Information
        7.6.2 Rebinyn Introduction and Business Overview
        7.6.3 Rebinyn Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.6.4 Rebinyn Recombinant Coagulation Factor Concentrate Product Offerings
        7.6.5 Rebinyn Recent Development
    7.7 Rixubis
        7.7.1 Rixubis Company Information
        7.7.2 Rixubis Introduction and Business Overview
        7.7.3 Rixubis Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.7.4 Rixubis Recombinant Coagulation Factor Concentrate Product Offerings
        7.7.5 Rixubis Recent Development
    7.8 CSL
        7.8.1 CSL Company Information
        7.8.2 CSL Introduction and Business Overview
        7.8.3 CSL Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.8.4 CSL Recombinant Coagulation Factor Concentrate Product Offerings
        7.8.5 CSL Recent Development
    7.9 Baxalta
        7.9.1 Baxalta Company Information
        7.9.2 Baxalta Introduction and Business Overview
        7.9.3 Baxalta Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.9.4 Baxalta Recombinant Coagulation Factor Concentrate Product Offerings
        7.9.5 Baxalta Recent Development
    7.10 Sanofi
        7.10.1 Sanofi Company Information
        7.10.2 Sanofi Introduction and Business Overview
        7.10.3 Sanofi Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.10.4 Sanofi Recombinant Coagulation Factor Concentrate Product Offerings
        7.10.5 Sanofi Recent Development
    7.11 Biogen
        7.11.1 Biogen Company Information
        7.11.2 Biogen Introduction and Business Overview
        7.11.3 Biogen Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.11.4 Biogen Recombinant Coagulation Factor Concentrate Product Offerings
        7.11.5 Biogen Recent Development
    7.12 Pfizer
        7.12.1 Pfizer Company Information
        7.12.2 Pfizer Introduction and Business Overview
        7.12.3 Pfizer Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.12.4 Pfizer Recombinant Coagulation Factor Concentrate Product Offerings
        7.12.5 Pfizer Recent Development
    7.13 Novo Disk
        7.13.1 Novo Disk Company Information
        7.13.2 Novo Disk Introduction and Business Overview
        7.13.3 Novo Disk Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.13.4 Novo Disk Recombinant Coagulation Factor Concentrate Product Offerings
        7.13.5 Novo Disk Recent Development
    7.14 Baxter
        7.14.1 Baxter Company Information
        7.14.2 Baxter Introduction and Business Overview
        7.14.3 Baxter Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.14.4 Baxter Recombinant Coagulation Factor Concentrate Product Offerings
        7.14.5 Baxter Recent Development
    7.15 Wyeth
        7.15.1 Wyeth Company Information
        7.15.2 Wyeth Introduction and Business Overview
        7.15.3 Wyeth Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.15.4 Wyeth Recombinant Coagulation Factor Concentrate Product Offerings
        7.15.5 Wyeth Recent Development
    7.16 Beijing Tiantan Biological Products
        7.16.1 Beijing Tiantan Biological Products Company Information
        7.16.2 Beijing Tiantan Biological Products Introduction and Business Overview
        7.16.3 Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.16.4 Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Product Offerings
        7.16.5 Beijing Tiantan Biological Products Recent Development
    7.17 SHANGHAI RAAS
        7.17.1 SHANGHAI RAAS Company Information
        7.17.2 SHANGHAI RAAS Introduction and Business Overview
        7.17.3 SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.17.4 SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Product Offerings
        7.17.5 SHANGHAI RAAS Recent Development
    7.18 Taibang Biologic Group
        7.18.1 Taibang Biologic Group Company Information
        7.18.2 Taibang Biologic Group Introduction and Business Overview
        7.18.3 Taibang Biologic Group Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.18.4 Taibang Biologic Group Recombinant Coagulation Factor Concentrate Product Offerings
        7.18.5 Taibang Biologic Group Recent Development
    7.19 HUALAN BIOLOGICAL ENGINEERING
        7.19.1 HUALAN BIOLOGICAL ENGINEERING Company Information
        7.19.2 HUALAN BIOLOGICAL ENGINEERING Introduction and Business Overview
        7.19.3 HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.19.4 HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Product Offerings
        7.19.5 HUALAN BIOLOGICAL ENGINEERING Recent Development
    7.20 Green Cross
        7.20.1 Green Cross Company Information
        7.20.2 Green Cross Introduction and Business Overview
        7.20.3 Green Cross Recombinant Coagulation Factor Concentrate Sales, Revenue, Price and Gross Margin (2019-2024)
        7.20.4 Green Cross Recombinant Coagulation Factor Concentrate Product Offerings
        7.20.5 Green Cross Recent Development

 8 Industry Chain Analysis
    8.1 Recombinant Coagulation Factor Concentrate Industrial Chain
    8.2 Recombinant Coagulation Factor Concentrate Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Recombinant Coagulation Factor Concentrate Sales Model
        8.5.2 Sales Channel
        8.5.3 Recombinant Coagulation Factor Concentrate Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Recombinant Coagulation Factor Concentrate Market Trends
 Table 2. Recombinant Coagulation Factor Concentrate Market Drivers & Opportunity
 Table 3. Recombinant Coagulation Factor Concentrate Market Challenges
 Table 4. Recombinant Coagulation Factor Concentrate Market Restraints
 Table 5. Global Recombinant Coagulation Factor Concentrate Revenue by Company (2019-2024) & (US$ Million)
 Table 6. Global Recombinant Coagulation Factor Concentrate Revenue Market Share by Company (2019-2024)
 Table 7. Global Recombinant Coagulation Factor Concentrate Sales Volume by Company (2019-2024) & (K Units)
 Table 8. Global Recombinant Coagulation Factor Concentrate Sales Volume Market Share by Company (2019-2024)
 Table 9. Global Market Recombinant Coagulation Factor Concentrate Price by Company (2019-2024) & (US$/Unit)
 Table 10. Key Manufacturers Recombinant Coagulation Factor Concentrate Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Recombinant Coagulation Factor Concentrate Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Recombinant Coagulation Factor Concentrate
 Table 13. Global Recombinant Coagulation Factor Concentrate Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Coagulation Factor Concentrate as of 2023)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Coagulation Factor Concentrate Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 17. Global Recombinant Coagulation Factor Concentrate Sales Value by Type (2019-2024) & (US$ Million)
 Table 18. Global Recombinant Coagulation Factor Concentrate Sales Value by Type (2025-2030) & (US$ Million)
 Table 19. Global Recombinant Coagulation Factor Concentrate Sales Market Share in Value by Type (2019-2024)
 Table 20. Global Recombinant Coagulation Factor Concentrate Sales Market Share in Value by Type (2025-2030)
 Table 21. Global Recombinant Coagulation Factor Concentrate Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
 Table 22. Global Recombinant Coagulation Factor Concentrate Sales Volume by Type (2019-2024) & (K Units)
 Table 23. Global Recombinant Coagulation Factor Concentrate Sales Volume by Type (2025-2030) & (K Units)
 Table 24. Global Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Type (2019-2024)
 Table 25. Global Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Type (2025-2030)
 Table 26. Global Recombinant Coagulation Factor Concentrate Price by Type (2019-2024) & (US$/Unit)
 Table 27. Global Recombinant Coagulation Factor Concentrate Price by Type (2025-2030) & (US$/Unit)
 Table 28. Global Recombinant Coagulation Factor Concentrate Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 29. Global Recombinant Coagulation Factor Concentrate Sales Value by Application (2019-2024) & (US$ Million)
 Table 30. Global Recombinant Coagulation Factor Concentrate Sales Value by Application (2025-2030) & (US$ Million)
 Table 31. Global Recombinant Coagulation Factor Concentrate Sales Market Share in Value by Application (2019-2024)
 Table 32. Global Recombinant Coagulation Factor Concentrate Sales Market Share in Value by Application (2025-2030)
 Table 33. Global Recombinant Coagulation Factor Concentrate Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
 Table 34. Global Recombinant Coagulation Factor Concentrate Sales Volume by Application (2019-2024) & (K Units)
 Table 35. Global Recombinant Coagulation Factor Concentrate Sales Volume by Application (2025-2030) & (K Units)
 Table 36. Global Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Application (2019-2024)
 Table 37. Global Recombinant Coagulation Factor Concentrate Sales Market Share in Volume by Application (2025-2030)
 Table 38. Global Recombinant Coagulation Factor Concentrate Price by Application (2019-2024) & (US$/Unit)
 Table 39. Global Recombinant Coagulation Factor Concentrate Price by Application (2025-2030) & (US$/Unit)
 Table 40. Global Recombinant Coagulation Factor Concentrate Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
 Table 41. Global Recombinant Coagulation Factor Concentrate Sales Value by Region (2019-2024) & (US$ Million)
 Table 42. Global Recombinant Coagulation Factor Concentrate Sales Value by Region (2025-2030) & (US$ Million)
 Table 43. Global Recombinant Coagulation Factor Concentrate Sales Value by Region (2019-2024) & (%)
 Table 44. Global Recombinant Coagulation Factor Concentrate Sales Value by Region (2025-2030) & (%)
 Table 45. Global Recombinant Coagulation Factor Concentrate Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
 Table 46. Global Recombinant Coagulation Factor Concentrate Sales Volume by Region (2019-2024) & (K Units)
 Table 47. Global Recombinant Coagulation Factor Concentrate Sales Volume by Region (2025-2030) & (K Units)
 Table 48. Global Recombinant Coagulation Factor Concentrate Sales Volume by Region (2019-2024) & (%)
 Table 49. Global Recombinant Coagulation Factor Concentrate Sales Volume by Region (2025-2030) & (%)
 Table 50. Global Recombinant Coagulation Factor Concentrate Average Price by Region (2019-2024) & (US$/Unit)
 Table 51. Global Recombinant Coagulation Factor Concentrate Average Price by Region (2025-2030) & (US$/Unit)
 Table 52. Key Countries/Regions Recombinant Coagulation Factor Concentrate Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
 Table 53. Key Countries/Regions Recombinant Coagulation Factor Concentrate Sales Value, (2019-2024) & (US$ Million)
 Table 54. Key Countries/Regions Recombinant Coagulation Factor Concentrate Sales Value, (2025-2030) & (US$ Million)
 Table 55. Key Countries/Regions Recombinant Coagulation Factor Concentrate Sales Volume, (2019-2024) & (K Units)
 Table 56. Key Countries/Regions Recombinant Coagulation Factor Concentrate Sales Volume, (2025-2030) & (K Units)
 Table 57. Bayer Company Information
 Table 58. Bayer Introduction and Business Overview
 Table 59. Bayer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 60. Bayer Recombinant Coagulation Factor Concentrate Product Offerings
 Table 61. Bayer Recent Development
 Table 62. Alprolix Company Information
 Table 63. Alprolix Introduction and Business Overview
 Table 64. Alprolix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 65. Alprolix Recombinant Coagulation Factor Concentrate Product Offerings
 Table 66. Alprolix Recent Development
 Table 67. Benefix Company Information
 Table 68. Benefix Introduction and Business Overview
 Table 69. Benefix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 70. Benefix Recombinant Coagulation Factor Concentrate Product Offerings
 Table 71. Benefix Recent Development
 Table 72. Idelvion Company Information
 Table 73. Idelvion Introduction and Business Overview
 Table 74. Idelvion Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 75. Idelvion Recombinant Coagulation Factor Concentrate Product Offerings
 Table 76. Idelvion Recent Development
 Table 77. Lxinity Company Information
 Table 78. Lxinity Introduction and Business Overview
 Table 79. Lxinity Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 80. Lxinity Recombinant Coagulation Factor Concentrate Product Offerings
 Table 81. Lxinity Recent Development
 Table 82. Rebinyn Company Information
 Table 83. Rebinyn Introduction and Business Overview
 Table 84. Rebinyn Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 85. Rebinyn Recombinant Coagulation Factor Concentrate Product Offerings
 Table 86. Rebinyn Recent Development
 Table 87. Rixubis Company Information
 Table 88. Rixubis Introduction and Business Overview
 Table 89. Rixubis Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 90. Rixubis Recombinant Coagulation Factor Concentrate Product Offerings
 Table 91. Rixubis Recent Development
 Table 92. CSL Company Information
 Table 93. CSL Introduction and Business Overview
 Table 94. CSL Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 95. CSL Recombinant Coagulation Factor Concentrate Product Offerings
 Table 96. CSL Recent Development
 Table 97. Baxalta Company Information
 Table 98. Baxalta Introduction and Business Overview
 Table 99. Baxalta Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 100. Baxalta Recombinant Coagulation Factor Concentrate Product Offerings
 Table 101. Baxalta Recent Development
 Table 102. Sanofi Company Information
 Table 103. Sanofi Introduction and Business Overview
 Table 104. Sanofi Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 105. Sanofi Recombinant Coagulation Factor Concentrate Product Offerings
 Table 106. Sanofi Recent Development
 Table 107. Biogen Company Information
 Table 108. Biogen Introduction and Business Overview
 Table 109. Biogen Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 110. Biogen Recombinant Coagulation Factor Concentrate Product Offerings
 Table 111. Biogen Recent Development
 Table 112. Pfizer Company Information
 Table 113. Pfizer Introduction and Business Overview
 Table 114. Pfizer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 115. Pfizer Recombinant Coagulation Factor Concentrate Product Offerings
 Table 116. Pfizer Recent Development
 Table 117. Novo Disk Company Information
 Table 118. Novo Disk Introduction and Business Overview
 Table 119. Novo Disk Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 120. Novo Disk Recombinant Coagulation Factor Concentrate Product Offerings
 Table 121. Novo Disk Recent Development
 Table 122. Baxter Company Information
 Table 123. Baxter Introduction and Business Overview
 Table 124. Baxter Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 125. Baxter Recombinant Coagulation Factor Concentrate Product Offerings
 Table 126. Baxter Recent Development
 Table 127. Wyeth Company Information
 Table 128. Wyeth Introduction and Business Overview
 Table 129. Wyeth Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 130. Wyeth Recombinant Coagulation Factor Concentrate Product Offerings
 Table 131. Wyeth Recent Development
 Table 132. Beijing Tiantan Biological Products Company Information
 Table 133. Beijing Tiantan Biological Products Introduction and Business Overview
 Table 134. Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 135. Beijing Tiantan Biological Products Recombinant Coagulation Factor Concentrate Product Offerings
 Table 136. Beijing Tiantan Biological Products Recent Development
 Table 137. SHANGHAI RAAS Company Information
 Table 138. SHANGHAI RAAS Introduction and Business Overview
 Table 139. SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 140. SHANGHAI RAAS Recombinant Coagulation Factor Concentrate Product Offerings
 Table 141. SHANGHAI RAAS Recent Development
 Table 142. Taibang Biologic Group Company Information
 Table 143. Taibang Biologic Group Introduction and Business Overview
 Table 144. Taibang Biologic Group Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 145. Taibang Biologic Group Recombinant Coagulation Factor Concentrate Product Offerings
 Table 146. Taibang Biologic Group Recent Development
 Table 147. HUALAN BIOLOGICAL ENGINEERING Company Information
 Table 148. HUALAN BIOLOGICAL ENGINEERING Introduction and Business Overview
 Table 149. HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 150. HUALAN BIOLOGICAL ENGINEERING Recombinant Coagulation Factor Concentrate Product Offerings
 Table 151. HUALAN BIOLOGICAL ENGINEERING Recent Development
 Table 152. Green Cross Company Information
 Table 153. Green Cross Introduction and Business Overview
 Table 154. Green Cross Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 155. Green Cross Recombinant Coagulation Factor Concentrate Product Offerings
 Table 156. Green Cross Recent Development
 Table 157. Key Raw Materials Lists
 Table 158. Raw Materials Key Suppliers Lists
 Table 159. Recombinant Coagulation Factor Concentrate Downstream Customers
 Table 160. Recombinant Coagulation Factor Concentrate Distributors List
 Table 161. Research Programs/Design for This Report
 Table 162. Key Data Information from Secondary Sources
 Table 163. Key Data Information from Primary Sources


List of Figures
 Figure 1. Recombinant Coagulation Factor Concentrate Product Picture
 Figure 2. Global Recombinant Coagulation Factor Concentrate Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Recombinant Coagulation Factor Concentrate Sales Value (2019-2030) & (US$ Million)
 Figure 4. Global Recombinant Coagulation Factor Concentrate Sales Volume (2019-2030) & (K Units)
 Figure 5. Global Recombinant Coagulation Factor Concentrate Sales Price (2019-2030) & (US$/Unit)
 Figure 6. Recombinant Coagulation Factor Concentrate Report Years Considered
 Figure 7. Global Recombinant Coagulation Factor Concentrate Players Revenue Ranking (2023) & (US$ Million)
 Figure 8. Global Recombinant Coagulation Factor Concentrate Players Sales Volume Ranking (2023) & (US$ Million)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Coagulation Factor Concentrate Revenue in 2023
 Figure 10. Recombinant Coagulation Factor Concentrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 11. 250 IU Picture
 Figure 12. 500 IU Picture
 Figure 13. 1000 IU Picture
 Figure 14. 2000 IU Picture
 Figure 15. Global Recombinant Coagulation Factor Concentrate Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 16. Global Recombinant Coagulation Factor Concentrate Sales Value Market Share by Type, 2023 & 2030
 Figure 17. Global Recombinant Coagulation Factor Concentrate Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
 Figure 18. Global Recombinant Coagulation Factor Concentrate Sales Volume Market Share by Type, 2023 & 2030
 Figure 19. Global Recombinant Coagulation Factor Concentrate Price by Type (2019-2030) & (US$/Unit)
 Figure 20. Product Picture of Hopistial
 Figure 21. Product Picture of Clinic
 Figure 22. Product Picture of Others
 Figure 23. Global Recombinant Coagulation Factor Concentrate Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 24. Global Recombinant Coagulation Factor Concentrate Sales Value Market Share by Application, 2023 & 2030
 Figure 25. Global Recombinant Coagulation Factor Concentrate Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
 Figure 26. Global Recombinant Coagulation Factor Concentrate Sales Volume Market Share by Application, 2023 & 2030
 Figure 27. Global Recombinant Coagulation Factor Concentrate Price by Application (2019-2030) & (US$/Unit)
 Figure 28. North America Recombinant Coagulation Factor Concentrate Sales Value (2019-2030) & (US$ Million)
 Figure 29. North America Recombinant Coagulation Factor Concentrate Sales Value by Country (%), 2023 VS 2030
 Figure 30. Europe Recombinant Coagulation Factor Concentrate Sales Value, (2019-2030) & (US$ Million)
 Figure 31. Europe Recombinant Coagulation Factor Concentrate Sales Value by Country (%), 2023 VS 2030
 Figure 32. Asia Pacific Recombinant Coagulation Factor Concentrate Sales Value, (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Recombinant Coagulation Factor Concentrate Sales Value by Region (%), 2023 VS 2030
 Figure 34. South America Recombinant Coagulation Factor Concentrate Sales Value, (2019-2030) & (US$ Million)
 Figure 35. South America Recombinant Coagulation Factor Concentrate Sales Value by Country (%), 2023 VS 2030
 Figure 36. Middle East & Africa Recombinant Coagulation Factor Concentrate Sales Value, (2019-2030) & (US$ Million)
 Figure 37. Middle East & Africa Recombinant Coagulation Factor Concentrate Sales Value by Country (%), 2023 VS 2030
 Figure 38. Key Countries/Regions Recombinant Coagulation Factor Concentrate Sales Value (%), (2019-2030)
 Figure 39. Key Countries/Regions Recombinant Coagulation Factor Concentrate Sales Volume (%), (2019-2030)
 Figure 40. United States Recombinant Coagulation Factor Concentrate Sales Value, (2019-2030) & (US$ Million)
 Figure 41. United States Recombinant Coagulation Factor Concentrate Sales Value by Type (%), 2023 VS 2030
 Figure 42. United States Recombinant Coagulation Factor Concentrate Sales Value by Application (%), 2023 VS 2030
 Figure 43. Europe Recombinant Coagulation Factor Concentrate Sales Value, (2019-2030) & (US$ Million)
 Figure 44. Europe Recombinant Coagulation Factor Concentrate Sales Value by Type (%), 2023 VS 2030
 Figure 45. Europe Recombinant Coagulation Factor Concentrate Sales Value by Application (%), 2023 VS 2030
 Figure 46. China Recombinant Coagulation Factor Concentrate Sales Value, (2019-2030) & (US$ Million)
 Figure 47. China Recombinant Coagulation Factor Concentrate Sales Value by Type (%), 2023 VS 2030
 Figure 48. China Recombinant Coagulation Factor Concentrate Sales Value by Application (%), 2023 VS 2030
 Figure 49. Japan Recombinant Coagulation Factor Concentrate Sales Value, (2019-2030) & (US$ Million)
 Figure 50. Japan Recombinant Coagulation Factor Concentrate Sales Value by Type (%), 2023 VS 2030
 Figure 51. Japan Recombinant Coagulation Factor Concentrate Sales Value by Application (%), 2023 VS 2030
 Figure 52. South Korea Recombinant Coagulation Factor Concentrate Sales Value, (2019-2030) & (US$ Million)
 Figure 53. South Korea Recombinant Coagulation Factor Concentrate Sales Value by Type (%), 2023 VS 2030
 Figure 54. South Korea Recombinant Coagulation Factor Concentrate Sales Value by Application (%), 2023 VS 2030
 Figure 55. Southeast Asia Recombinant Coagulation Factor Concentrate Sales Value, (2019-2030) & (US$ Million)
 Figure 56. Southeast Asia Recombinant Coagulation Factor Concentrate Sales Value by Type (%), 2023 VS 2030
 Figure 57. Southeast Asia Recombinant Coagulation Factor Concentrate Sales Value by Application (%), 2023 VS 2030
 Figure 58. India Recombinant Coagulation Factor Concentrate Sales Value, (2019-2030) & (US$ Million)
 Figure 59. India Recombinant Coagulation Factor Concentrate Sales Value by Type (%), 2023 VS 2030
 Figure 60. India Recombinant Coagulation Factor Concentrate Sales Value by Application (%), 2023 VS 2030
 Figure 61. Recombinant Coagulation Factor Concentrate Industrial Chain
 Figure 62. Recombinant Coagulation Factor Concentrate Manufacturing Cost Structure
 Figure 63. Channels of Distribution (Direct Sales, and Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed

Description

The global market for Recombinant Coagulation Factor Concentrate was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.

Coagulation factor is the main drug for the treatment of hemophilia, and it has experienced the evolution and development from the first generation blood-derived coagulation factor products to the second generation recombinant products and the third generation long-acting recombinant products. Recombinant coagulation factors avoid the possibility of human infection and get rid of the dependence on plasma; long-acting products improve patient compliance and treatment convenience by prolonging the half-life of drugs, and long-acting recombinant coagulation factors are the trend of future research and development.

Market Segmentation